A distinct inflammatory profile marked by neutrophil activity and cytokine elevation may underline poor biological response ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

Biologics, including medications like mepolizumab and dupilumab, are widely prescribed for patients with severe asthma and ...

Biological drugs have been a game-changer for people with severe asthma, helping them breathe easier and live more ...

While biological drugs (biologics) have significantly improved the quality of life for individuals with severe asthma, new ...

While biological drugs or biologics have improved the lives of many people with severe asthma, a new study shows that some ...

Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet ...